Brainstorm Cell Therapeutics Now Covered by Analysts at StockNews.com

BCLI Stock  USD 1.60  0.02  1.27%   
Under 51% of Brainstorm Cell's traders are presently thinking to get in. The analysis of the overall investor sentiment regarding Brainstorm Cell Therapeutics suggests that some traders are interested. Brainstorm Cell's investing sentiment shows overall attitude of investors towards Brainstorm Cell Therapeutics.
  
StockNews.com began coverage on shares of Brainstorm Cell Therapeutics in a report issued on Thursday morning. The brokerage issued a hold rating on the biotechnology companys stock. Brainstorm Cell Therapeutics Price Performance Shares of NASDAQ BCLI opened at 0.38 on Thursday. Brainstorm Cell Therapeutics has a one year low of 0.13

Read at thelincolnianonline.com
news
  

Brainstorm Cell Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Brainstorm Cell can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Brainstorm Cell Fundamental Analysis

We analyze Brainstorm Cell's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Brainstorm Cell using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Brainstorm Cell based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Current Valuation

Current Valuation Comparative Analysis

Brainstorm Cell is currently under evaluation in current valuation category among its peers. Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Brainstorm Cell Ther Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Brainstorm Cell stock to make a market-neutral strategy. Peer analysis of Brainstorm Cell could also be used in its relative valuation, which is a method of valuing Brainstorm Cell by comparing valuation metrics with similar companies.

Peers

Brainstorm Cell Related Equities

XFORX4 Pharmaceuticals   8.11   
0%
41.0%
GBIOGeneration Bio   7.41   
0%
38.0%
HOWLWerewolf Therapeutics   6.90   
0%
35.0%
BCABBioatla   6.45   
0%
33.0%
CKPTCheckpoint Therapeutics   5.54   
0%
28.0%
CCCCC4 Therapeutics   4.23   
0%
21.0%
ANTXAN2 Therapeutics   2.70   
0%
13.0%
HCWBHCW Biologics   2.70   
0%
13.0%
CRVSCorvus Pharmaceuticals   2.54   
0%
13.0%
PASGPassage Bio   1.96   
0%
10.0%
CNTBConnect Biopharma   1.11   
0%
5.0%
TRVITrevi Therapeutics   0.44   
0%
2.0%
CELCCelcuity LLC   0.74   
3.0%
0%
CUECue Biopharma   0.81   
4.0%
0%
EWTXEdgewise Therapeutics   0.83   
4.0%
0%
INZYInozyme Pharma   0.83   
4.0%
0%
GRIGRI Bio   0.88   
4.0%
0%
TERNTerns Pharmaceuticals   1.86   
9.0%
0%
MREOMereo BioPharma   2.04   
10.0%
0%
PLXProtalix Biotherapeutics   2.10   
10.0%
0%
DAWNDay One   4.03   
20.0%
0%
ALDXAldeyra   19.40   
100.0%
0%

Complementary Tools for Brainstorm Stock analysis

When running Brainstorm Cell's price analysis, check to measure Brainstorm Cell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brainstorm Cell is operating at the current time. Most of Brainstorm Cell's value examination focuses on studying past and present price action to predict the probability of Brainstorm Cell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brainstorm Cell's price. Additionally, you may evaluate how the addition of Brainstorm Cell to your portfolios can decrease your overall portfolio volatility.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Fundamental Analysis
View fundamental data based on most recent published financial statements
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing